Zdrowie i gospodarka · 27/05/2020
FDA Announces Draft Recommendations for Residual Solvents in Pharmaceuticals
The FDA is releasing draft guidelines for the permitted daily exposures to residual solvents in pharmaceuticals, developed in collaboration with the International Council for Harmonisation, to ensure patient safety.
Source: Federal Register — Food and Drug AdministrationOpen original release →